High-DNA Stainability Is Not Related to Embryonic Development and Clinical Outcomes on In Vitro Fertilization Cycles: A Retrospective Study Using a Propensity Score-Matching Analysis

Table 3

Intergroup difference of clinical outcomes, and logistic regression analysis on the contribution of HDS levels to clinical outcome after matching.

	HDS > 15% group; (n = 161)	HDS ≤ 15% group; (n = 467)	P-value	OR; (95% CI)	P-value	AOR; (95% CI)	P-value
Clinical pregnancy rate (%)	62.11; (100/161)	60.39; (282/467)	0.699	1.000; (0.977–1.025)	0.968	0.997; (0.973–1.023)	0.837
Ongoing pregnancy rate (%)	52.17; (84/161)	53.10; (248/467)	0.838	1.000; (0.977–1.023)	0.998	0.995; (0.971–1.019)	0.682
Early miscarriage rate (%)	9.94; (16/161)	7.28; (34/467)	0.283	1.001; (0.957–1.042)	0.946	1.009; (0.963–1.052)	0.698
Late miscarriage rate (%)	0.62; (1/161)	2.14; (10/467)	0.305	0.946; (0.826–1.042)	0.338	0.929; (0.796–1.033)	0.259
Live birth rate (%)	51.55; (83/161)	50.96; (238/467)	0.897	1.003; (0.980–1.026)	0.799	0.999; (0.975–1.024)	0.957

Note: OR, odds ratio; AOR, adjusted odds ratio.